Analyst upgrades, especially from reputable financial institutions like Morgan Stanley, can significantly influence investor sentiment and stock prices. The upgrade to Overweight suggests a strong bullish outlook on Invivyd, and the substantial increase in the price target from $4 to $10 indicates a positive reassessment of the company's value and growth prospects. This is likely to attract more investors to the stock, driving up its price in the short term.